Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: Nov 21, 2025, 4:00 PM EST
1.290
-0.050 (-3.73%)
After-hours: Nov 21, 2025, 4:09 PM EST

Zentalis Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
26.8767.43----
Upgrade
Gross Profit
26.8767.43----
Upgrade
Selling, General & Admin
69.8287.1259.454.5540.9433.89
Upgrade
Research & Development
109.63167.77189.59172.73166.884.9
Upgrade
Operating Expenses
179.45254.88248.99227.29207.74118.79
Upgrade
Operating Income
-152.58-187.46-248.99-227.29-207.74-118.79
Upgrade
Interest & Investment Income
12.2712.279.462.261.311.24
Upgrade
Earnings From Equity Investments
---16.01-16.28-1.83-
Upgrade
EBT Excluding Unusual Items
-143.86-175.18-255.54-241.31-208.26-117.55
Upgrade
Impairment of Goodwill
-3.74-3.74----
Upgrade
Gain (Loss) on Sale of Investments
6.413.2313.163.73-0.91-0.56
Upgrade
Gain (Loss) on Sale of Assets
0.62---51.58-
Upgrade
Asset Writedown
-1.15--4.95--8.8-
Upgrade
Pretax Income
-149.52-165.69-292.91-237.58-166.39-118.1
Upgrade
Income Tax Expense
-0.210.18-0.6-0.47-0.30.44
Upgrade
Earnings From Continuing Operations
-149.32-165.87-292.31-237.11-166.09-118.55
Upgrade
Minority Interest in Earnings
-0.030.110.317.370.71
Upgrade
Net Income
-149.32-165.84-292.19-236.81-158.73-117.84
Upgrade
Net Income to Common
-149.32-165.84-292.19-236.81-158.73-117.84
Upgrade
Shares Outstanding (Basic)
727165534328
Upgrade
Shares Outstanding (Diluted)
727165534328
Upgrade
Shares Change (YoY)
1.13%8.67%23.75%23.82%51.84%402.29%
Upgrade
EPS (Basic)
-2.08-2.33-4.47-4.48-3.72-4.19
Upgrade
EPS (Diluted)
-2.08-2.33-4.47-4.48-3.72-4.19
Upgrade
Free Cash Flow
-134.01-171.08-208.41-166.3-160.2-87.58
Upgrade
Free Cash Flow Per Share
-1.87-2.41-3.19-3.15-3.75-3.12
Upgrade
Gross Margin
100.00%100.00%----
Upgrade
Operating Margin
-567.95%-278.02%----
Upgrade
Profit Margin
-555.80%-245.96%----
Upgrade
Free Cash Flow Margin
-498.82%-253.74%----
Upgrade
EBITDA
-151.68-186.17-247.6-225.86-207.2-118.63
Upgrade
EBITDA Margin
--276.11%----
Upgrade
D&A For EBITDA
0.91.291.391.430.540.16
Upgrade
EBIT
-152.58-187.46-248.99-227.29-207.74-118.79
Upgrade
EBIT Margin
--278.02%----
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q